STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
246.10
+2.63 (1.08%)
Feb 12, 2026, 1:02 PM EST - Market open
STERIS Revenue
STERIS had revenue of $1.46B in the quarter ending September 30, 2025, with 9.89% growth. This brings the company's revenue in the last twelve months to $5.70B, up 7.08% year-over-year. In the fiscal year ending March 31, 2025, STERIS had annual revenue of $5.46B with 6.24% growth.
Revenue (ttm)
$5.70B
Revenue Growth
+7.08%
P/S Ratio
4.11
Revenue / Employee
$327,656
Employees
17,787
Market Cap
24.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.46B | 320.81M | 6.24% |
| Mar 31, 2024 | 5.14B | 602.44M | 13.28% |
| Mar 31, 2023 | 4.54B | 312.86M | 7.41% |
| Mar 31, 2022 | 4.22B | 1.12B | 35.91% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | 3.03B | 248.73M | 8.94% |
| Mar 31, 2019 | 2.78B | 162.17M | 6.19% |
| Mar 31, 2018 | 2.62B | 7.24M | 0.28% |
| Mar 31, 2017 | 2.61B | 373.99M | 16.71% |
| Mar 31, 2016 | 2.24B | 388.50M | 21.00% |
| Mar 31, 2015 | 1.85B | 228.01M | 14.06% |
| Mar 31, 2014 | 1.62B | 120.35M | 8.01% |
| Mar 31, 2013 | 1.50B | 95.09M | 6.76% |
| Mar 31, 2012 | 1.41B | 199.36M | 16.51% |
| Mar 31, 2011 | 1.21B | -50.29M | -4.00% |
| Mar 31, 2010 | 1.26B | -40.79M | -3.14% |
| Mar 31, 2009 | 1.30B | 33.44M | 2.64% |
| Mar 31, 2008 | 1.27B | 67.68M | 5.65% |
| Mar 31, 2007 | 1.20B | 37.12M | 3.20% |
| Mar 31, 2006 | 1.16B | 78.61M | 7.27% |
| Mar 31, 2005 | 1.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.86B |
| GE HealthCare Technologies | 20.63B |
| Zimmer Biomet Holdings | 8.01B |
| Smith & Nephew | 5.94B |
| Edwards Lifesciences | 5.88B |
| DexCom | 4.52B |
| Globus Medical | 2.77B |
| Bio-Rad Laboratories | 2.56B |
STE News
- 6 days ago - STERIS: A Bump In The Road For A Reliable Name - Seeking Alpha
- 7 days ago - STERIS plc (STE) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 7 days ago - STERIS Announces Financial Results for Fiscal 2026 Third Quarter - GlobeNewsWire
- 14 days ago - STERIS Announces Dividend of $0.63 per share - GlobeNewsWire
- 21 days ago - STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026 - GlobeNewsWire
- 22 days ago - METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors - Business Wire
- 3 months ago - STERIS plc (STE) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - STERIS Announces Financial Results for Fiscal 2026 Second Quarter - GlobeNewsWire